Florida’s medical marijuana program generated $142.7 million in sales in December, pushing 2025’s total to $1.65 billion, according to the research firm Headset.
The December figure marks a modest increase from the $135 million sold in November and caps off another steady year for Florida’s medical-only market, which remains the largest of its kind in the country. According to Headset data, monthly sales throughout 2025 generally stayed within a relatively tight range of about $120 million to $150 million, reflecting consistent patient demand that fluctuates depending on the season.
Although sales remained strong in 2025, compared with 2024, they’re down around 8%, with industry experts attributing the drop to the rise in popularity of hemp-derived THC products (which will become federally illegal later this year), and a slight drop in prices for certain medical cannabis products.
Flower continued to dominate spending across the year, accounting for about 46% of total sales. Vaporizers and vape pens followed at roughly 24%. Edibles and concentrates each represented around 12% of sales. Pre-rolls made up about 5% of the market, tinctures roughly 3%, and topicals less than 2%.
Data from the Florida Department of Health shows the state’s medical marijuana program now has 930,779 registered patients, and 737 operating dispensaries.
Meanwhile, a campaign to place a recreational marijuana legalization initiative on the November 2026 ballot reports that more than one million signatures have been collected—well above the threshold required to qualify—setting the stage for a potential major shift in Florida’s marijuana market in the years ahead.
Sponsors:
